Weekly Recap | Synopsys -11.02%, insider selling stokes a sharp pullback
I'm LongbridgeAI, I can summarize articles.Synopsys (SNPS) fell 11.02% this week to close at $393.84, while the S&P 500 added 0.09%. The stock underperformed the benchmark by about 11.11 percentage points. The week started on a firm note on Monday (31 Aug), opening at $437.95 and hitting an intraday high of $445.86 before settling at $439.59. Tuesday (1 Sep) opened lower and slid to $414.82, a drop of close to 6%. Wednesday (2 Sep) and Thursday (3 Sep) traded narrowly between $413 and $416.
The Week
Synopsys (SNPS) fell 11.02% this week to close at $393.84, while the S&P 500 added 0.09%. The stock underperformed the benchmark by about 11.11 percentage points. The week started on a firm note on Monday (31 Aug), opening at $437.95 and hitting an intraday high of $445.86 before settling at $439.59. Tuesday (1 Sep) opened lower and slid to $414.82, a drop of close to 6%. Wednesday (2 Sep) and Thursday (3 Sep) traded narrowly between $413 and $416. Friday (4 Sep) saw another leg down on heavier volume, with the low at $380.325 before a close at $393.84. Weekly amplitude reached 14.96%, and average daily volume ran about 16.8% above the 60-day median.
Key Events
The dominant thread this week was selling by the executive chairman and the related headlines that followed. A Q3 2026 earnings call transcript was released on the evening of 31 Aug. From 1 Sep, several filings showed Executive Chair Aart de Geus disposing of common shares: one disclosure on 1 Sep was worth about $11.14 million, and another on 3 Sep covered 49,641 shares worth about $21.35 million. Media reports linked the share decline to the insider selling: the stock fell 5.4% on 1 Sep, closed down 5.63%, then fell nearly 8% intraday on 4 Sep before closing 5.56% lower. There were also position disclosures from institutions, such as Beacon Pointe Advisors taking a stake and Northwestern Mutual holding about $6.96 million in shares, but these did not drive the week’s narrative.
Analyst Ratings
Among 27 covering institutions, 16 rate the stock buy, 4 overweight, 4 hold, 1 underweight and 2 have no opinion, with no sell ratings. The consensus rating is buy. The consensus target price is $544.97231, about 38.37% above the latest price of $393.84. Individual targets range from a low of $414.77 to a high of $633, showing wide dispersion. Within an industry group of 200 application software names, Synopsys ranks 14th in analyst rating, above the industry median.
The Week Ahead
There are no company-specific earnings on Synopsys’ calendar next week, but the macro schedule is fairly heavy. On Tuesday, 8 Sep, the NFIB small business optimism index is due. On Thursday, 10 Sep, a batch of US data arrives, including initial jobless claims, final demand PPI, core final demand PPI, existing home sales, wholesale sales and 10-year Treasury auction figures. AI infrastructure stocks have been navigating between Fed pressure and data-centre demand, so the macro data could keep influencing sentiment across the sector.
In Short
Synopsys’ price action this week tracked closely with news of insider selling. The stock swung between $380 and $445 and finished Friday near the lower end of that range on higher volume. Analysts remain constructive, with a consensus buy rating and a target about 38% above the latest price, while the latest session’s fund flow showed large-lot money tilting to the sell side and valuation sits around 70x P/E. The key level to watch is whether the $380 area holds, alongside next week’s dense macro data and its effect on growth-stock sentiment.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
